MTOR and malignant conjunctival melanoma: In tumoral tissues of conjunctival melanomas, we and others have previously reported the activation of Mitogen-Activated Protein Kinase (MAPK) and possibly phosphoinositide 3-kinase (PI3k)/mTOR pathways [18,19].